Type IV fimbrial subunit protein ApfA contributes to protection against porcine pleuropneumonia

Veterinary Research

Volumn 43, Issue 1, 2012, Pages

  Sadilkova, Lenka ^a   Nepereny, Jiri ^b   Vrzal, Vladimir ^b   Sebo, Peter ^a   Osicka, Radim ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b Bioveta A S ^*  (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOBACILLUS PLEUROPNEUMONIAE; MYCOPLASMA; SUIDAE; SUS;

ADHESIN; BACTERIAL VACCINE; EXOTOXIN; RECOMBINANT PROTEIN; VIRULENCE FACTOR;

ACTINOBACILLUS INFECTION; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL; ANIMAL DISEASE; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; FEMALE; FIMBRIA; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PNEUMONIA; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; SWINE; SWINE DISEASE; VACCINATION;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ADHESINS, BACTERIAL; ANIMALS; BACTERIAL VACCINES; ESCHERICHIA COLI; EXOTOXINS; FEMALE; FIMBRIAE, BACTERIAL; MALE; MOLECULAR SEQUENCE DATA; PLEUROPNEUMONIA; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; SWINE; SWINE DISEASES; VACCINATION; VIRULENCE FACTORS;

EID: 84858110532     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-43-2     Document Type: Article

References (78)

1. Actinobacillus pleuropneumoniae. Gottschalk M, Taylor DJ, Diseases of Swine Ames, Iowa: Blackwell Publishing, Straw BE, Zimmerman JJ, D'Allaire S, Taylor DJ, 9 2006 563 576
2. Haemophilus pleuropneumoniae infection in swine: a review. Sebunya TN, Saunders JR, J Am Vet Med Assoc 1983 182 1331 1337 6348003
3. Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host. Chiers K, De Waele T, Pasmans F, Ducatelle R, Haesebrouck F, Vet Res 2010 41 65 10.1051/vetres/2010037 20546697
4. Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Bosse JT, Janson H, Sheehan BJ, Beddek AJ, Rycroft AN, Kroll JS, Langford PR, Microbes Infect 2002 4 225 235 10.1016/S1286-4579(01)01534-9 11880056 (Pubitemid 34183498)
5. Comparative virulence of porcine Haemophilus bacteria. Rosendal S, Boyd DA, Gilbride KA, Can J Comp Med 1985 49 68 74 3986682 (Pubitemid 15146974)
6. Porcine contagious Pleuropneumonia. II. Studies of the pathogenicity of the etiological agent, Hemophilus pleuropneumoniae. Shope RE, White DC, Leidy G, J Exp Med 1964 119 369 375 10.1084/jem.119.3.369 14129708
7. Sequential study of lesion development in experimental haemophilus pleuropneumonia. Liggett AD, Harrison LR, Farrell RL, Res Vet Sci 1987 42 204 212 3589167
8. Porcine Haemophilus pleuropneumonia epizootic in southwestern Ontario: clinical, microbiological, pathological and some epidemiological findings. Sanford SE, Josephson GK, Can J Comp Med 1981 45 2 7 7272838 (Pubitemid 11184940)
9. Haemophilus pleuropneumoniae infection in pigs. Jones MA, The veterinary annual Bristol, England: John Wright and Sons Ltd, Grunsell CSG, Hill FWG, 1984 24 148 154
10. Efficacy of vaccines against bacterial diseases in swine: what can we expect? Haesebrouck F, Pasmans F, Chiers K, Maes D, Ducatelle R, Decostere A, Vet Microbiol 2004 100 255 268 10.1016/j.vetmic.2004.03.002 15145504 (Pubitemid 38625696)
11. Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies. Ramjeet M, Deslandes V, Goure J, Jacques M, Anim Health Res Rev 2008 9 25 45 10.1017/S1466252307001338 18346296
12. Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15. Blackall PJ, Klaasen HL, van den Bosch H, Kuhnert P, Frey J, Vet Microbiol 2002 84 47 52 10.1016/S0378-1135(01)00428-X 11731158 (Pubitemid 33135530)
13. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity. Dubreuil JD, Jacques M, Mittal KR, Gottschalk M, Anim Health Res Rev 2000 1 73 93 10.1017/S1466252300000074 11708600
14. Surface polysaccharides and iron-uptake systems of Actinobacillus pleuropneumoniae. Jacques M, Can J Vet Res 2004 68 81 85 15188950 (Pubitemid 38735681)
15. Evaluation of a killed vaccine against porcine pleuropneumonia due to Haemophilus pleuropneumoniae. Higgins R, Lariviere S, Mittal KR, Martineau GP, Rousseau P, Cameron J, Can Vet J 1985 26 86 89 17422508
16. Haemophilus pleuropneumoniae serotypes - cross protection experiments. Nielsen R, Nord Vet Med 1984 36 221 234 6493974
17. Haemophilus pleuropneumoniae (Actinobacillus pleuropneumoniae). Serotypes 8, 3 and 6. Serological response and cross immunity in pigs. Nielsen R, Nord Vet Med 1985 37 217 227 4059042
18. Host cell contact-induced transcription of the type IV fimbria gene cluster of Actinobacillus pleuropneumoniae. Boekema BK, Van Putten JP, Stockhofe-Zurwieden N, Smith HE, Infect Immun 2004 72 691 700 10.1128/IAI.72.2.691-700.2004 14742510 (Pubitemid 38166645)
19. Expression of the apxIV gene in pigs naturally infected with Actinobacillus pleuropneumoniae. Cho WS, Chae C, J Comp Pathol 2001 125 34 40 10.1053/jcpa.2001.0474 11437514 (Pubitemid 32631572)
20. Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection. Haesebrouck F, Chiers K, Van Overbeke I, Ducatelle R, Vet Microbiol 1997 58 239 249 10.1016/S0378-1135(97)00162-4 9453134 (Pubitemid 28026787)
21. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia. Haga Y, Ogino S, Ohashi S, Ajito T, Hashimoto K, Sawada T, J Vet Med Sci 1997 59 115 120 10.1292/jvms.59.115 9070983 (Pubitemid 127523980)
22. The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice. Seah JN, Frey J, Kwang J, Infect Immun 2002 70 6464 6467 10.1128/IAI.70.11.6464-6467.2002 12379729 (Pubitemid 35192742)
23. Convalescent pigs are protected completely against infection with a homologous Actinobacillus pleuropneumoniae strain but incompletely against a heterologous-serotype strain. Cruijsen T, van Leengoed LA, Ham-Hoffies M, Verheijden JH, Infect Immun 1995 63 2341 2343 7768619
24. Cross-protection between Actinobacillus pleuropneumoniae biotypes-serotypes in pigs. Haesebrouk F, Van de Kerkhof A, Dom P, Chiers K, Ducatelle R, Vet Microbiol 1996 52 277 284 10.1016/S0378-1135(96)00075-2 8972053 (Pubitemid 26393711)
25. Actinobacillus pleuropneumoniae iron transport and urease activity: effects on bacterial virulence and host immune response. Baltes N, Tonpitak W, Gerlach GF, Hennig-Pauka I, Hoffmann-Moujahid A, Ganter M, Rothkotter HJ, Infect Immun 2001 69 472 478 10.1128/IAI.69.1.472-478.2001 11119539 (Pubitemid 32038346)
26. Immunization with temperature-sensitive mutants of Actinobacillus pleuropneumoniae induces protective hemolysin-neutralizing antibodies in mice. Byrd W, Hooke AM, Curr Microbiol 1997 34 149 154 10.1007/s002849900160 9009067 (Pubitemid 27085945)
27. A riboflavin auxotroph of Actinobacillus pleuropneumoniae is attenuated in swine. Fuller TE, Thacker BJ, Mulks MH, Infect Immun 1996 64 4659 4664 8890222 (Pubitemid 26357074)
28. Actinobacillus pleuropneumoniae serotype 1 carrying the defined aroA mutation is fully avirulent in the pig. Garside LH, Collins M, Langford PR, Rycroft AN, Res Vet Sci 2002 72 163 167 10.1053/rvsc.2002.0554 12027598 (Pubitemid 34679296)
29. Attenuation of Actinobacillus pleuropneumoniae by inactivation of aroQ. Ingham A, Zhang Y, Prideaux C, Vet Microbiol 2002 84 263 273 10.1016/S0378-1135(01)00465-5 11731178 (Pubitemid 33135550)
30. Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals. Maas A, Jacobsen ID, Meens J, Gerlach GF, Infect Immun 2006 74 4124 4132 10.1128/IAI.00133-06 16790786 (Pubitemid 43993345)
31. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon. Prideaux CT, Lenghaus C, Krywult J, Hodgson AL, Infect Immun 1999 67 1962 1966 10085043 (Pubitemid 29144422)
32. Protection of mice against challenge with homologous and heterologous serovars of Actinobacillus pleuropneumoniae after live vaccination. Prideaux CT, Pierce L, Krywult J, Hodgson AL, Curr Microbiol 1998 37 324 332 10.1007/s002849900386 9767712 (Pubitemid 28563409)
33. Comparison of the efficacy of a subunit and a live streptomycin-dependent porcine pleuropneumonia vaccine. Tumamao JQ, Bowles RE, van den Bosch H, Klaasen HL, Fenwick BW, Storie GJ, Blackall PJ, Aust Vet J 2004 82 370 374 10.1111/j.1751-0813.2004.tb11108.x 15272463 (Pubitemid 44769011)
34. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae. Xu F, Chen X, Shi A, Yang B, Wang J, Li Y, Guo X, Blackall PJ, Yang H, Vet Microbiol 2006 118 230 239 10.1016/j.vetmic.2006.07.013 16930871 (Pubitemid 44755469)
35. Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C(-) mutant lacking a drug resistance marker in the pigs. Bei W, He Q, Zhou R, Yan L, Huang H, Chen H, Vet Microbiol 2007 125 120 127 10.1016/j.vetmic.2007.05.013 17580102 (Pubitemid 47446064)
36. Construction and immunogencity of a DeltaapxIC/DeltaapxIIC double mutant of Actinobacillus pleuropneumoniae serovar 1. Lin L, Bei W, Sha Y, Liu J, Guo Y, Liu W, Tu S, He Q, Chen H, FEMS Microbiol Lett 2007 274 55 62 10.1111/j.1574-6968.2007.00813.x 17608699 (Pubitemid 47174307)
37. Nucleotide sequence of the hemolysin I gene from Actinobacillus pleuropneumoniae. Frey J, Meier R, Gygi D, Nicolet J, Infect Immun 1991 59 3026 3032 1879928
38. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Frey J, Trends Microbiol 1995 3 257 261 10.1016/S0966-842X(00)88939-8 7551637
39. Analysis of hemolysin operons in Actinobacillus pleuropneumoniae. Frey J, Beck M, Stucki U, Nicolet J, Gene 1993 123 51 58 10.1016/0378-1119(93)90538-E 8423004 (Pubitemid 23035791)
40. Development of an efficient PCR method for toxin typing of Actinobacillus pleuropneumoniae strains. Frey J, Beck M, van den Bosch JF, Segers RP, Nicolet J, Mol Cell Probes 1995 9 277 282 10.1016/S0890-8508(95)90158-2 7477024
41. Actinobacillus pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genes. Frey J, Bosse JT, Chang YF, Cullen JM, Fenwick B, Gerlach GF, Gygi D, Haesebrouck F, Inzana TJ, Jansen R, Kamp M, Macdonald J, MacInnes JI, Mittal KR, Nicolet J, Rycroft AN, Segers RP, Smits MA, Stenbaek E, Struck DK, van den Bosch, Willson PJ, Young R, J Gen Microbiol 1993 139 1723 1728 8409915 (Pubitemid 23258597)
42. RTX proteins: a highly diverse family secreted by a common mechanism. Linhartova I, Bumba L, Masin J, Basler M, Osicka R, Kamanova J, Prochazkova K, Adkins I, Hejnova-Holubova J, Sadilkova L, Morová J, Sebo P, FEMS Microbiol Rev 2010 34 1076 1112 20528947
43. Hemolysin patterns of Actinobacillus pleuropneumoniae. Frey J, Nicolet J, J Clin Microbiol 1990 28 232 236 2312671 (Pubitemid 20050926)
44. Identification of hemolytic and cytotoxic proteins of Actinobacillus pleuropneumoniae by use of monoclonal antibodies. Kamp EM, Popma JK, Anakotta J, Smits MA, Infect Immun 1991 59 3079 3085 1879932
45. Evaluation of heat-sensitive, neutrophil-toxic, and hemolytic activity of Haemophilus (Actinobacillus) pleuropneumoniae. Rosendal S, Devenish J, MacInnes JI, Lumsden JH, Watson S, Xun H, Am J Vet Res 1988 49 1053 1058 3421527
46. The cytotoxin of Actinobacillus pleuropneumoniae (pleurotoxin) is distinct from the haemolysin and is associated with a 120 kDa polypeptide. Rycroft AN, Williams D, Cullen JM, Macdonald J, J Gen Microbiol 1991 137 561 568 2033378
47. Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins. Chiers K, van Overbeke I, De Laender P, Ducatelle R, Carel S, Haesebrouck F, Vet Q 1998 20 65 69 10.1080/01652176.1998.9694841 9563163 (Pubitemid 28180174)
48. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins. Van Overbeke I, Chiers K, Ducatelle R, Haesebrouck F, J Vet Med B Infect Dis Vet Public Health 2001 48 15 20 10.1046/j.1439-0450. 2001.00419.x 11254095 (Pubitemid 32176961)
49. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae. Wang C, Wang Y, Shao M, Si W, Liu H, Chang Y, Peng W, Kong X, Liu S, Vaccine 2009 27 5816 5821 10.1016/j.vaccine.2009.07.065 19654060
50. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae. Schaller A, Kuhn R, Kuhnert P, Nicolet J, Anderson TJ, MacInnes JI, Segers RP, Frey J, Microbiology 1999 145 2105 2116 10.1099/13500872-145-8-2105 10463177 (Pubitemid 29396941)
51. Identification and characterization of a porcine-specific transferrin receptor in Actinobacillus pleuropneumoniae. Gonzalez GC, Caamano DL, Schryvers AB, Mol Microbiol 1990 4 1173 1179 10.1111/j.1365-2958.1990.tb00692.x 2233254 (Pubitemid 20245168)
52. Both transferrin binding proteins are virulence factors in Actinobacillus pleuropneumoniae serotype 7 infection. Baltes N, Hennig-Pauka I, Gerlach GF, FEMS Microbiol Lett 2002 209 283 287 10.1111/j.1574-6968.2002.tb11145.x 12007819 (Pubitemid 34465605)
53. Immunization of pigs against Actinobacillus pleuropneumoniae with two recombinant protein preparations. Rossi-Campos A, Anderson C, Gerlach GF, Klashinsky S, Potter AA, Willson PJ, Vaccine 1992 10 512 518 10.1016/0264-410X(92)90349-O 1621414
54. Identification and characterization of novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae. Oldfield NJ, Donovan EA, Worrall KE, Wooldridge KG, Langford PR, Rycroft AN, Ala'Aldeen DA, Vaccine 2008 26 1942 1954 10.1016/j.vaccine.2008.02.022 18342410
55. Identification of type 4 fimbriae in Actinobacillus pleuropneumoniae. Zhang Y, Tennent JM, Ingham A, Beddome G, Prideaux C, Michalski WP, FEMS Microbiol Lett 2000 189 15 18 10.1111/j.1574-6968.2000.tb09199.x 10913859 (Pubitemid 30456240)
56. Demonstration of Type IV pilus expression and a twitching phenotype by Haemophilus influenzae. Bakaletz LO, Baker BD, Jurcisek JA, Harrison A, Novotny LA, Bookwalter JE, Mungur R, Munson RS Jr, Infect Immun 2005 73 1635 1643 10.1128/IAI.73.3.1635-1643.2005 15731063 (Pubitemid 40470751)
57. Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation. Luke NR, Howlett AJ, Shao J, Campagnari AA, Infect Immun 2004 72 6262 6270 10.1128/IAI.72.11.6262-6270. 2004 15501752 (Pubitemid 39425403)
58. Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Bieber D, Ramer SW, Wu CY, Murray WJ, Tobe T, Fernandez R, Schoolnik GK, Science 1998 280 2114 2118 10.1126/science.280.5372. 2114 9641917 (Pubitemid 28366204)
59. A systematic genetic analysis in Neisseria meningitidis defines the Pil proteins required for assembly, functionality, stabilization and export of type IV pili. Carbonnelle E, Helaine S, Nassif X, Pelicic V, Mol Microbiol 2006 61 1510 1522 10.1111/j.1365-2958.2006.05341.x 16968224 (Pubitemid 44359379)
60. Genetic and functional characterization of the gene cluster specifying expression of Pseudomonas aeruginosa pili. Koga T, Ishimoto K, Lory S, Infect Immun 1993 61 1371 1377 7681046 (Pubitemid 23099209)
61. Type IV pili and cell motility. Wall D, Kaiser D, Mol Microbiol 1999 32 1 10 10.1046/j.1365-2958.1999.01339.x 10216854 (Pubitemid 29167183)
62. Type IV pilus structure and bacterial pathogenicity. Craig L, Pique ME, Tainer JA, Nat Rev Microbiol 2004 2 363 378 10.1038/nrmicro885 15100690 (Pubitemid 39490116)
63. Type IV pilin structures: insights on shared architecture, fiber assembly, receptor binding and type II secretion. Hansen JK, Forest KT, J Mol Microbiol Biotechnol 2006 11 192 207 10.1159/000094054 16983195 (Pubitemid 44414055)
64. Cloning and characterisation of type 4 fimbrial genes from Actinobacillus pleuropneumoniae. Stevenson A, Macdonald J, Roberts M, Vet Microbiol 2003 92 121 134 10.1016/S0378-1135(02)00351-6 12488076 (Pubitemid 35477662)
65. Molecular cloning: a laboratory manual. Sambrook J, Fritsch EF, Maniatis T, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., USA 2 1989
66. The complete genome sequence of Actinobacillus pleuropneumoniae L20 (serotype 5b). Foote SJ, Bosse JT, Bouevitch AB, Langford PR, Young NM, Nash JH, J Bacteriol 2008 190 1495 1496 10.1128/JB.01845-07 18065534 (Pubitemid 351215034)
67. Genome biology of Actinobacillus pleuropneumoniae JL03, an isolate of serotype 3 prevalent in China. Xu Z, Zhou Y, Li L, Zhou R, Xiao S, Wan Y, Zhang S, Wang K, Li W, Jin H, Kang M, Dalai B, Li T, Liu L, Cheng Y, Zhang L, Xu T, Zheng H, Pu S, Wang B, Gu W, Zhang XL, Zhu GF, Wang S, Zhao GP, Chen H, PLoS One 2008 3 1450 10.1371/journal.pone.0001450 18197260 (Pubitemid 351255433)
68. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs. van den Bosch H, Frey J, Vaccine 2003 21 3601 3607 10.1016/S0264-410X(03)00410-9 12922088 (Pubitemid 37338183)
69. Serotype distribution of Actinobacillus pleuropneumoniae isolated from porcine pleuropneumonia in the Czech Republic during period 2003-2004. Kucerova Z, Jaglic Z, Ondriasova R, Nedbalcova K, Veterinarni Medicina-UZPI (Czech Republic) 2005 50 355 360 (Pubitemid 41329747)
70. Identification and serotyping of Haemophilus pleuropneumoniae by coagglutination test. Mittal KR, Higgins R, Lariviere S, J Clin Microbiol 1983 18 1351 1354 6655041 (Pubitemid 14235630)
71. Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice. Shao M, Wang Y, Wang C, Guo Y, Peng Y, Liu J, Li G, Liu H, Liu S, Acta Vet Scand 2010 52 52 10.1186/1751-0147-52-52 20831818
72. The protection given by pilus and whole cell vaccines of Bacteroides nodosus strain 198 against ovine foot-rot induced by strains of different serogroups. Stewart DJ, Clark BL, Peterson JE, Emery DL, Smith EF, Griffiths DA, O'Donnell IJ, Aust Vet J 1985 62 153 159 10.1111/j.1751-0813.1985.tb07277.x 2864040
73. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis. Lepper AW, Moore LJ, Atwell JL, Tennent JM, Vet Microbiol 1992 32 177 187 10.1016/0378-1135(92)90104-2 1359693
74. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK). Lepper AW, Atwell JL, Lehrbach PR, Schwartzkoff CL, Egerton JR, Tennent JM, Vet Microbiol 1995 45 129 138 10.1016/0378-1135(94)00123-E 7571364
75. Efficacy trial of a parenteral gonococcal pilus vaccine in men. Boslego JW, Tramont EC, Chung RC, McChesney DG, Ciak J, Sadoff JC, Piziak MV, Brown JD, Brinton CC, Wood SW, Bryan JR, Vaccine 1991 9 154 162 10.1016/0264-410X(91) 90147-X 1675029
76. In vivo association of Actinobacillus pleuropneumoniae serotype 2 with the respiratory epithelium of pigs. Dom P, Haesebrouck F, Ducatelle R, Charlier G, Infect Immun 1994 62 1262 1267 7907578 (Pubitemid 24110818)
77. Binding of Actinobacillus pleuropneumoniae to phosphatidylethanolamine. Jeannotte ME, Abul-Milh M, Dubreuil JD, Jacques M, Infect Immun 2003 71 4657 4663 10.1128/IAI.71.8.4657-4663.2003 12874346 (Pubitemid 36919933)
78. Characterization of the in vitro adhesion of Actinobacillus pleuropneumoniae to swine alveolar epithelial cells. Van Overbeke I, Chiers K, Charlier G, Vandenberghe I, Van Beeumen J, Ducatelle R, Haesebrouck F, Vet Microbiol 2002 88 59 74 10.1016/S0378-1135(02)00080-9 12119138 (Pubitemid 34761965)